CHC Healthcare Group (TPE:4164)

Taiwan · Delayed Price · Currency is TWD

25.50

+0.30 (1.19%)

Sep 11, 2026, 1:30 PM CST

Market Cap	4.95B -45.0%
Revenue (ttm)	4.65B +14.1%
Net Income	225.96M +20.8%
EPS	1.16 +14.8%
Shares Out	193.94M
PE Ratio	21.92
Forward PE	n/a
Dividend	1.10 (4.25%)
Ex-Dividend Date	Jun 29, 2026

Volume	272,293
Open	25.20
Previous Close	25.20
Day's Range	25.20 - 25.50
52-Week Range	25.05 - 49.85
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supple... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2009

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4164

Full Company Profile

Financial Performance

In 2025, CHC Healthcare Group's revenue was 4.40 billion, an increase of 22.15% compared to the previous year's 3.60 billion. Earnings were 186.28 million, an increase of 10.63%.

Financial Statements